Neuropathology and pathogenesis of dementia with lewy bodies

Dementia with Lewy Bodies: and Parkinson's Disease Dementia

Volumn , Issue , 2005, Pages 149-166

  Dickson, Dennis W ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953657050     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (63)

1. Aarsland D, Ballard CG, Halliday G, Are Parkinson’s disease with dementia and dementia with Lewy bodies the same entity? J Geriatr Psychiatry Neurol (2004) 17:137-45.
2. Albin RL, Minoshima S, D’Amato CJ et al, Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology (1996) 47:462-6.
3. Apaydin H, Ahlskog JE, Parisi JE et al, Parkinson’s disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol (2002) 59:102-12.
4. Arriagada PV, Growdon JH, Hedley-Whyte ET et al, Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology (1992) 42:31-9.
5. Baba M, Nakajo S, Tu PH, Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies. Am J Pathol (1998) 152:879-84.
6. Baker M, Litvan I, Houlden H et al, Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet (1999) 8:711-15.
7. Boeve BF, Silber MH, Ferman TJ, REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol (2004) 17:146-57.
8. Braak H, Braak E, Neuropathologic staging of Alzheimer-related changes. Acta Neuropathol (1991) 82:239-59.
9. Braak H, Del Tredici K, Rüb U et al, Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging (2003) 24:197-211.
10. Chiba-Falek O, Touchman JE, Mussbaun RL, Functional analysis of intra-allelic variation at NACP-Rep 1 in the alpha-synuclein gene. Human Genet (2003) 113:426-31.
11. Churchyard A, Lees A, The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson’s disease. Neurology (1997) 49:1570-6.
12. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR, Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol (1999) 58:376-88.
13. Dickson DW, Pathogenesis of senile plaques. J Neuropathol Exp Neurol (1997) 56:321-39.
14. Dickson DW, a-synuclein and the Lewy body disorders. Curr Opin Neurol (2001) 14: 423-32.
15. Dickson DW, Dementia with Lewy bodies: neuropathology. J Geriat Psychiatry Neurol (2002a) 15:210-16.
16. Dickson DW, Neuropathology of Parkinsonian disorders. In: Jankovic JJ, Tolosa E, eds, Parkinson’s Disease and Movement Disorders (4th edn) (Lippincott Williams & Wilkins: Philadelphia, 2002b) 256-69.
17. Dickson DW, Davies P, Mayeux R et al, Diffuse Lewy body disease: Neuropathological and biochemical studies of six patients. Acta Neuropathol (1987) 75:8-15.
18. Dickson DW, Ruan D, Crystal H et al, Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer’s disease: Light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology (1991) 41:1402-9.
19. Dickson DW, Wu E, Crystal HA et al, Alzheimer and age-related pathology in diffuse Lewy body disease. In: Boiler F, Forcette F, Khachaturian Z, et al, eds, Heterogeneity of Alzheimer’s Disease (Springer-Verlag: Berlin, 1992) 168-86.
20. Dickson DW, Crystal HA, Davies P, Hardy J, Cytoskeletal and Alzheimer type pathology in Lewy body disease. In: Perry RH, McKeith IG, Perry EK, eds, Dementia with Lewy Bodies (Cambridge University Press: Cambridge, 1996) 224-37.
21. Duda JE, Giasson BI, Mabon ME et al, Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol (2002). 52:205-10.
22. Emre M, Dementia associated with Parkinson’s disease. Lancet Neurol (2003) 2:229-37.
23. Eriksen JL, Wszolek Z, Petrucelli L, Molecular pathogenesis of Parkinson disease. Arch Neurol (2005) 62:353-7.
24. Farrer M, Marganore DM, Lockhart P et al, Alpha-synuclein gene haplotypes are associated with Parkinson’s disease. Hum Mol Genet (2001) 10:1847-51.
25. Fujino Y, Dickson DW, Spongiosis in Alzheimer’s disease not due to concurrent Lewy body disease. J Neuropathol Exp Neurol (2003) 62:553.
26. Galvin JE, Lee VM, Babà M et al, Monoclonal antibodies to purified cortical Lewy bodies recognize the mid-size neurofilament subunit. Ann Neurol (1997) 42:595-603.
27. Grober E, Dickson D, Sliwinski MJ et al, Memory and mental status correlates of modified Braak staging. Neurobiol Aging (1999) 20:573-79.
28. Gwinn-Hardy K, Mehta ND, Farrer M et al, Distinctive neuropathology revealed by a-synuclein antibodies in hereditary Parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol (2000) 99:663-72.
29. Hamilton RL, Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol (2000) 10:378-84.
30. Hansen LA, Masliah E, Terry RD, Mirra SS, A neuropathological subset of Alzheimer’s disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol (1989) 78:194-201.
31. Hansen LA, Daniel SE, Wilcock GK, Love S, Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer’s disease and dementia. J Neurol Neurosurg Psychiatry (1998) 64:653-6.
32. Harding AJ, Halliday GM, Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol (2001) 102:355-63.
33. Harding AJ, Broe GA, Halliday GM, Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain (2002) 125:391-403.
34. Healy DG, Abou-Sleiman PM, Lees AJ et al, Tau gene and Parkinson’s disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry (2004) 75:962-5.
35. Higuchi M, Tashiro M, Arai H et al, Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Exp Neurol (2000) 162:247-56.
36. Hyman BT, Trojanowski JQ, Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol (1997) 56: 1095-7.
37. Ishizawa T, Mattila P, Davies P et al, Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J Neuropath Exp Neurol (2003) 62:389-97.
38. Jellinger KA, Mizuno Y, Parkinson’s disease. In: Dickson DW, ed, Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders (ISN Neuropath Press: Basel, 2003) 159-87.
39. Kato S, Nakamura H, Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultra-structural studies. Acta Neuropathol (1990) 79:584-94.
40. Khachaturian ZS, Diagnosis of Alzheimer’s disease. Arch Neurol (1985) 42:1097-105.
41. Knopman DS, Parisi JE, Salviati A et al, Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol (2003) 62:1087-95.
42. Kosaka K, Yoshimura M, Ikeda K, Budka H, Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree - a new disease? Clin Neuropathol (1984) 3:185-92.
43. Kuzuhara S, Mori H, Izumiyama N et al, Lewy bodies are ubiquitinated: a light and electron microscopic immunocytochemical study. Acta Neuropathol (1988) 75:345-53.
44. Langlais PJ, Thal L, Hansen L et al, Neurotransmitters in basal ganglia and cortex of Alzheimer’s disease with and without Lewy bodies. Neurology (1993) 43: 1927-34.
45. Lantos PL, The definition of multiple system atrophy: a review of recent developments. J Neuropathol Exp Neurol (1998) 57:1099-1111.
46. Lennox G, Lowe JS, Landon M et al, Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry (1989) 52:1236-47.
47. Maraganore DM, Hernandez DG, Singleton AB, Case-control study of the extended tau gene haplotype in Parkinson’s disease. Ann Neurol (2001) 50:658-61.
48. McKeith IG, Galasko D, Kosaka K et al, Clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on Dementia with Lewy Bodies International Workshop. Neurology (1996) 47:1113-24.
49. McKeith IG, Ballard CG, Perry RH et al, Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology (2000) 54:1050-8.
50. McKeith I, Mintzer J, Aarsland D et al, International Psychogeriatric Association Expert Meeting on DLB. Dementia with Lewy bodies. Lancet Neurol (2004) 3:19-28.
51. Masliah E, Rockenstein E, Veinbergs I et al, Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer’s disease and Parkinson’s disease. Proc Natl Acad Sei USA (2001) 98:12245-50.
52. Mirra SS, Heyman A, McKeel D et al, The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology (1991) 41:479-86.
53. Perry EK, Smith CJ, Court JA, Perry RH, Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. J Neural Transm Park Dis Dement Sect (1990) 2:149-58.
54. Petersen R, Mild cognitive impairment as a diagnostic entity. J Intern Med (2004) 256:183-94.
55. Pollanen MS, Bergeron C, Weyer L, Detergent insoluble cortical Lewy body fibrils share epitopes with neurofilament and tau. J Neurochem (1992) 58:1953-6.
56. Pollanen MS, Dickson DW, Bergeron C, Pathology and biology of the Lewy body. J Neuropathol Exp Neurol (1993) 52:183-91.
57. Rajput AH, Uitti RJ, Stern W, Laverty W, Early onset Parkinson’s disease in Saskatchewan - environmental considerations for etiology. Can J Neurol Sci (1986) 13:312-6.
58. Samuel W, Galasko D, Masliah E, Hansen LA, Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer’s disease. J Neuropathol Exp Neurol (1996) 55:44-52.
59. Singleton AB, Wharton A, O’Brien KK et al, Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies. Dement Geriatr Cogn Disord (2002) 14:167-75.
60. Singleton AB, Farrer M, Johnson J et al, Alpha-synuclein locus triplication causes Parkinson’s disease. Science (2003) 302:841.
61. Wakabayashi K, Takahashi H, Neuropathology of autonomic nervous system in Parkinson’s disease. Eur Neurol (1997) 38(Suppl 2):2-7.
62. Wakabayashi K, Hayashi S, Yoshimoto M et al, NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains. Acta Neuropathol (2000) 99:14-20.
63. Wu E, Lipton RD, Dickson DW, Amyloid angiopathy in diffuse Lewy body disease. Neurology (1992) 42, 2131-2135.